Neal van Hoeven

Company: Cabaletta Bio

Job title: Vice President - Preclinical Research

Seminars:

Bridging In Vitro and In Vivo Data with a Targeted Approach to De-Risking Cell Therapy Safety in Autoimmunity 10:00 am

Leveraging focused in vitro binding data to select clinically relevant in vivo models for cell therapy safety assessment Using biochemical profiling to guide predictive model selection for autoimmune cell therapies Leveraging pan-autoimmunity insights to streamline model developmentRead more

day: Conference Day One